Clinical trial Recruiting at 1 site Interventional Ages 18 and up

MiGo Tracker remote monitoring to support home arm exercises after a stroke

Official title: MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke

Run by Flint Rehabilitation Devices, LLC · NCT06752707 · Data updated 2026-11-12

This program will test whether using the MiGo Tracker to remotely monitor home arm exercises helps people within 30 days after a stroke improve arm movement and stick with their exercises.

More Subacute Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorFlint Rehabilitation Devices, LLC
Industry-sponsored
Locations1 site (Downey, California)
StatusRecruiting
StartedJune 11, 2025
Main results expectedMarch 31, 2026
Study endsAugust 31, 2026
Registry record updatedJuly 16, 2025
Trial IDNCT06752707 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults within 30 days of a stroke who have some upper-extremity movement (Fugl-Meyer >5 and ≤55), can follow two-step commands, and have no other major neurological or severe medical problems.

Probably not a fit

People under 18, those unable to follow two-step commands, those with other neurological diagnoses or serious concurrent illnesses, and those with very minimal or extremely severe arm impairment are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial enrolling 50 people with subacute stroke to compare a MiGo Tracker remote therapeutic monitoring (RTM) program versus a conventional home exercise prescription without monitoring. Participants will be randomly assigned to the MiGo RTM intervention or usual care and will continue to receive standard outpatient rehabilitation. The primary outcome is motor recovery measured three months after stroke, with safety and adherence tracked throughout the study. Eligible participants have had a stroke within 30 days and have measurable upper-extremity impairment based on Fugl-Meyer scores.

Why it matters

Potential benefit: If successful, the MiGo Tracker could increase home exercise adherence and improve arm motor recovery for many people after stroke.

How similar studies have gone: Wearable and remote-monitoring approaches for post-stroke rehabilitation have shown promising early results for improving adherence and activity, but large randomized evidence in the subacute period remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Experienced one or more strokes less than one month (30 days) prior
* Upper Extremity Fugl-Meyer Score \> 5 and \<= 55 out of 66
* Absence of moderate to severe pain (\<= 4 on the 10 point visual-analog pain scale)

Exclusion Criteria:

* age \<18 years old
* Unable to follow 2-step commands
* Other neurological diagnosis (e.g. Parkinson's Disease)
* Other severe concurrent medical conditions that may prevent the participants from completing the 3-month study

Where it's running

  • Rancho Research Institute, Inc
    Downey, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.